Affiliation: University of Melbourne
- Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosisDarryl Wade
Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
J Clin Psychiatry 68:767-74. 2007..To investigate whether severity of substance use disorder is independently associated with 15-month symptomatic or functional outcome in young individuals with first-episode psychosis...
- Examination of the latent factor structure of the Alcohol Use Disorders Identification Test in two independent trauma patient groups using confirmatory factor analysisDarryl Wade
Australian Centre for Posttraumatic Mental Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
J Subst Abuse Treat 43:123-8. 2012..An algorithm is proposed to inform alcohol screening protocols in a range of health settings for trauma-exposed patient groups...
- Substance misuse in first-episode psychosis: 15-month prospective follow-up studyD Wade
ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, and Department of Medicine, University of Melbourne at St Vincent s Hospital, Fitzroy, Victoria, Australia
Br J Psychiatry 189:229-34. 2006..Well-designed prospective studies of substance misuse in first-episode psychosis can improve our understanding of the risks associated with comorbid substance misuse and psychosis...
- Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosisDarryl Wade
ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia
Aust N Z J Psychiatry 40:429-36. 2006..The second aim was to determine whether the pattern of inpatient admission during this period was associated with remission of psychotic symptoms or inpatient service use at 15-month follow-up...
- Course of substance misuse and daily tobacco use in first-episode psychosisDarryl Wade
ORYGEN Youth Health, Locked Bag 10, Parkville, VIC 3052, Australia
Schizophr Res 81:145-50. 2006..Study of the course of substance misuse and daily tobacco use in first-episode psychosis may enhance detection and treatment of these substance-related problems...
- Differential predictors of critical comments and emotional over-involvement in first-episode psychosisM Alvarez-Jimenez
Orygen Youth Health Research Centre, Melbourne, Victoria, Australia
Psychol Med 40:63-72. 2010..The purpose of this study was to investigate the differential relationships of EOI and CC with relevant predictors in relatives of first-episode psychosis (FEP) patients...
- Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosisDarryl Wade
ORYGEN Youth Health and Department of Psychiatry, University of Melbourne, Victoria, Australia
Aust N Z J Psychiatry 39:892-8. 2005..To investigate the patterns and predictors of substance use disorders (SUD) and daily tobacco use in first-episode psychosis (FEP)...
- Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot studyBrendan P Murphy
ORYGEN Youth Heath, Melbourne, Australia
Hum Psychopharmacol 21:511-7. 2006..We undertook a prospective, open-label pilot trial to investigate the use of amisulpride in the treatment of young people with FEP characterised by primary negative symptoms...
- Antibodies to infectious agents in individuals at ultra-high risk for psychosisG Paul Amminger
ORYGEN Research Centre, Department of Psychiatry, University of Melbourne, Australia
Biol Psychiatry 61:1215-7. 2007..While there is evidence that some cases of schizophrenia may be associated with microbial infections, the role of microbial agents has not been investigated in people with emerging psychosis...
- Cannabis use and schizophreniaDarryl Wade
Am J Psychiatry 162:401; author reply 402. 2005
- A service response to prolonged recovery in early psychosisJane Edwards
Mental Health Services for Kids and Youth, North West Mental Health Program, Parville, Victoria, Australia
Psychiatr Serv 53:1067-9. 2002